PapersPMID:37207866
Lutein targeting orbital fibroblasts attenuates fibrotic and inflammatory effects in thyroid-associated ophthalmopathy.
- findings
- 4
- compound
- 1
- endpoints
- 4
- Study, every finding
- in vitro · not in humans
- Population, every finding
- orbital fibroblasts from patients with thyroid-associated ophthalmopathy, treated with TGF-β1 to induce fibrosis
What moved
How to read these marks →“LU inhibited ACTA2, COL1A1, FN1, and CTGF mRNA expression and suppressed α-SMA, and FN1 protein expression induced by TGF-β1.”
- Inhibits CCN2
insufficient
- Inhibits COL1A1
insufficient
- Inhibits FN1
insufficient
- Inhibits ACTA2
insufficient
Study record
- Design
- in vitro / mechanistic study
- Species
- cells
- Population
- orbital fibroblasts (OFs) cultured from patients with thyroid-associated ophthalmopathy (TAO) and from non-TAO controls, pre-treated with lutein then challenged with TGF-β1 (fibrosis) or IL-1β (inflammation, oxidative stress)
- Participants
- not reported
- Comparator
- placebo
- Duration
- not reported
- Endpoints measured
- 5
lutein